Regulatory Mechanism of Mangiferin Combined with Bortezomib on Malignant Biological Behavior of Burkitt Lymphoma and Its Effect on Expression of CXC Chemokine Receptors.
10.19746/j.cnki.issn.1009-2137.2023.05.022
- Author:
Zhi-Min YAN
1
;
Yan-Quan LIU
2
;
Qing-Lin XU
2
;
Jie LIN
2
;
Xin LIU
2
;
Qiu-Ping ZHU
2
;
Xin-Ji CHEN
3
;
Ting-Bo LIU
3
;
Xiao-Lan LIAN
3
Author Information
1. Department of Hematology, The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, Jiangxi Province, China.E-mail: yanzhimin81@tmu.edu.cn.
2. Department of Intensive Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, Jiangxi Province, China.
3. Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, Fujian Province, China.
- Publication Type:Journal Article
- Keywords:
Burkitt lymphoma;
CXC chemokine receptor;
bortezomib;
malignant biological behavior;
mangiferin;
regulatory mechanism
- MeSH:
Humans;
Antineoplastic Agents/therapeutic use*;
Apoptosis/drug effects*;
Apoptosis Regulatory Proteins/immunology*;
Autophagy/immunology*;
bcl-2-Associated X Protein/immunology*;
Bortezomib/therapeutic use*;
Burkitt Lymphoma/immunology*;
Cell Line, Tumor;
Cell Proliferation/drug effects*;
Drug Therapy, Combination;
Proto-Oncogene Proteins c-akt;
Proto-Oncogene Proteins c-bcl-2;
Receptors, CXCR/immunology*;
RNA, Messenger;
TOR Serine-Threonine Kinases;
Xanthones/therapeutic use*
- From:
Journal of Experimental Hematology
2023;31(5):1394-1402
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the effects of mangiferin combined with bortezomib on the proliferation, invasion, apoptosis and autophagy of human Burkitt lymphoma Raji cells, as well as the expression of CXC chemokine receptors (CXCRs) family, and explore the molecular mechanism between them to provide scientific basis for basic research and clinical work of Burkitt lymphoma.
METHODS:Raji cells were intervened with different concentrations of mangiferin and bortezomib alone or in combination, then cell proliferation was detected by CCK-8 assay, cell invasion ability was detected by Transwell chamber method, cell apoptosis was detected by Annexin V/PI double-staining flow cytometry, apoptosis, autophagy and Akt/mTOR pathway protein expression were detected by Western blot, and the expression changes of CXCR family was detected by real-time quantitative PCR (RT-qPCR).
RESULTS:Different concentrations of mangiferin intervened Raji cells for different time could inhibit cell viability in a concentration- and time-dependent manner (r =-0.682, r =-0.836). When Raji cells were intervened by combination of mangiferin and bortezomib, compared with single drug group, the proliferation and invasion abilities were significantly decreased, while the apoptosis level was significantly increased (P <0.01). Mangiferin combined with bortezomib could significantly up-regulate the expression of pro-apoptotic protein Bax and down-regulate the expression of anti-apoptotic protein Bcl-2 after intervention in Raji cells. Caspase-3 was also hydrolyzed and activated, and then induced the apoptosis of Raji cells. Mangiferin combined with bortezomib could up-regulate the expression of LC3Ⅱ protein in Raji cells, and the ratio of LC3Ⅱ/LC3Ⅰ in cells was significantly up-regulated compared with single drug or control group (P <0.01). Mangiferin combined with bortezomib could significantly inhibit the phosphorylation levels of Akt and mTOR, inhibit the proliferation and invasion of Raji cells by inhibiting Akt/mTOR pathway, and induce cell autophagy and apoptosis. Mangiferin and bortezomib could down-regulate the expressions of CXCR4 and CXCR7 mRNA after single-agent intervention in Raji cells, and the down-regulations of CXCR4 and CXCR7 mRNA expression were more significant when the two drugs were combined (P <0.01). Mangiferin alone or combined with bortezomib had no significant effect on CXCR5 mRNA expression in Raji cells (P >0.05), while the combination of the two drugs could down-regulate the expression of CXCR3 (P <0.05).
CONCLUSION:Mangiferin combined with bortezomib can synergistically inhibit the proliferation and invasion of Raji cells, and induce autophagy and apoptosis. The mechanism may be related to the inhibition of Akt/mTOR signaling pathway, down-regulation of anti-apoptotic protein Bcl-2 and up-regulation of pro-apoptotic protein Bax, and the inhibition of the expression of CXCR family.
